Tracon Pharmaceuticals, Inc.
TCONDelisted Jul 19, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001394319
Tracon Pharmaceuticals, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Mar 13, 2024; 29 institutions reported holding it in 13F filings for Q1 2024, worth $1.39M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Tracon Pharmaceuticals, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 35 | 35 | 0 |
| Shares | 9.16M | 9.13M | −28.5K (−0.3%) |
| Value | $25.4M | $24.0M | −$1.35M (−5.3%) |
New holders (5)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 10,403 | $27.0K | 0.00% |
| UBS Group AG | 4,828 | $13.0K | 0.00% |
| Royal Bank of Canada | 4,000 | $11.0K | 0.00% |
| Group One Trading, L.P. | 3,600 | $9.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 262 | $1.00K | 0.00% |
Sold out (5)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Acadian Asset Management LLC | 20,523 | $55.0K |
| Susquehanna International Group, LLP | 19,729 | $55.0K |
| Coastal Bridge Advisors, LLC | 11,900 | $32.0K |
| Bank of America Corp | 786 | $2.00K |
| Truvestments Capital LLC | 318 | $1.00K |